Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
pancreatitis
How Serious Is This News for Diabetes Drugmakers?
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
AstraZeneca
Bristol-Myers Squibb
diabetes
Merck
pancreatitis
type 2 diabetes
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Bloomberg
Bristol-Myers Squibb
Byetta
diabetes
Januvia
Merck
pancreatitis
Repligen Announces FDA Advisory Committee Date for SecreFlo™ NDA
Repligen Announces FDA Advisory Committee Date for SecreFlo™ NDA
Yahoo/BusinessWire
pancreatitis
Repligen
SecreFlo
Diabetes Meds, Pancreatitis & Prescribing Habits
Diabetes Meds, Pancreatitis & Prescribing Habits
Pharmalot
Amylin
Byetta
diabetes
Januvia
Merck
pancreatitis
physicians
News
Another Diabetes Drug is Linked to Pancreas Inflammation
WSJ Online
diabetes
Januvia
Merck
pancreatitis
»
Login
or
register
to post comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT